Toggle navigation
Home
Search
Services
Blog
Contact
About
Toxicol Agents That Stimulates Fetal Hemoglobin Product
Loveday, Kenneth S.
American Biogenics Corporation, Woburn, MA, United States
Search 8 grants from Kenneth Loveday
Search grants from American Biogenics Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Modeling Post Menopausal Chemotherapy-Associated Weight Gain
Core - Cytogenetics and Molecular Genetics Facility
Molecular Systematics of the Mangabeys (Cercocebus and Lophocebus)
ACT/SGER: (ACT - PHY) Characterizing Community Evolution and Communication Patterns in Social Networks
Nationalism and Ethnicity Among Salvadoran Immigrants
Recently added grants:
Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans
Preoperative Image Updating for Guidance during Brain Tumor Resection
Epigenetic Mechanisms Driving Synovial Sarcomagenesis
Understanding Long Tail Driver Mutations in Cancer
Investigating the role of KLF5 genomic alterations in tumorigenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Blood Diseases And Resources (NHLBI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43HB067016-001
Application #
3645657
Study Section
Project Start
1986-09-01
Project End
Budget Start
1987-07-15
Budget End
1987-02-28
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
American Biogenics Corporation
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1986
N43 HB
Toxicol Agents That Stimulates Fetal Hemoglobin Product
Loveday, Kenneth S. / American Biogenics Corporation
NIH 1986
N43 HB
Toxicol Agents That Stimulates Fetal Hemoglobin Product
Loveday, Kenneth S. / American Biogenics Corporation
Comments
Be the first to comment on Kenneth Loveday's grant